Abdominoplasty after bariatric surgery: comparison of three different techniques

The Role of Helium Plasma-Assisted Liposuction in Lipoabdominoplasty After Weight loss

BACKGROUND

Weight loss patients present with major deformities, leading to the rapid development of new body contouring techniques to address their specificities. Abdominal skin laxity is often major due to rapid weight loss and inflammation secondary to bariatric surgeries and is often present in both vertical and horizontal axes. Through this article, the authors wish to demonstrate the use of helium plasma radiofrequency technology for supraumbilical skin tightening following lipoabdominoplasty.

METHODS

A retrospective single-center cohort study was performed, including 100 consecutive patients undergoing HPRF-assisted lipoabdominoplasty. Patient characteristics, intra- and postoperative outcomes and complications were collected. A postoperative Likert scale evaluated patient satisfaction at 6-month follow-up.

RESULTS

The mean age was 37, and the median preoperative BMI was 25.3. The median follow-up period was 19.7 months. Among the 100 included patients, no major complication occurred. Minor complications included wound dehiscence (1%), subcutaneous emphysema (2%), hyperpigmentation (8%), seroma (6%), and hematoma (2%). Overall satisfaction was high with 88% of 5/5 evaluations on the Likert scale.

CONCLUSION

HPRF-assisted lipoabdominoplasty stands as a safe and efficient refinement in post-bariatric patients and can be used to avoid vertical scars and decrease scar tension. This technology seems, therefore, valuable to enhance body contouring procedures while minimizing morbidity.

LEVEL OF EVIDENCE IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine Ratings, please refer to Table of Contents or online Instructions to Authors www.springer.com/00266 .

The Global Prevalence of Seroma After Abdominoplasty: A Systematic Review and Meta-Analysis

BACKGROUND

Abdominoplasty is one of the most common cosmetic surgeries performed worldwide. Seroma is also the most common local complication associated with abdominoplasty, which increases care costs, reduces patient satisfaction, and has serious complications for patients. Results of previous studies report different levels of seroma prevalence after abdominoplasty. The aim of this study is to standardize the statistics of the prevalence of seroma after abdominoplasty using meta-analysis.

METHODS

In this systematic review and meta-analysis study, data from studies conducted on the global prevalence of seroma after abdominoplasty was extracted using the keywords "Prevalence, Epidemiology, Complications, Abdominoplasty, Seroma, and Lipo abdominoplasty" in the databases of Science, Scientific Information Database, MagIran, Embase, Scopus, PubMed, Web of Science, and Google Scholar search engine without time limit until October 2020. The random-effects model was used to analyze the eligible studies, and the heterogeneity of the studies was investigated with the I² index. Data analysis was performed using Comprehensive Meta-Analysis software (Version 2).

RESULTS

In reviewing 143 studies (five studies related to Asia, 55 studies related to Europe, three studies related to Africa, and 80 studies related to the Americas) with a total sample size of 27834 individuals, the global prevalence of seroma after abdominoplasty was obtained as 10.9% (95% CI: 9.3-3.6.6%) and the highest prevalence of seroma was related to the Europe continent with 12.8% (95% CI: 10.15-3.9%). The results from meta-regression showed a declining trend in the global prevalence of seroma after abdominoplasty with an increase in the sample size, age of study participants, and the year of study (p < 0.05).

CONCLUSIONS

This study shows that the prevalence of seroma after abdominoplasty is high globally. Therefore, physicians and specialists must consider its importance and take the controlling and treatment measures seriously.

LEVEL OF EVIDENCE III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine Ratings, please refer to Table of Contents or online Instructions to Authors www.springer.com/00266 .